Peer-reviewedCC BYMedicina (Kaunas, Lithuania)
Why Outcomes Diverge in Chronic Hepatitis B with Steatotic Liver Disease: Lessons from Within-Study Contrasts
- 1Department of Gastroenterology, Beijing Ditan Hospital, , No. 8 Jingshun East Street, Chaoyang District, Beijing 100015, China; (X.Y.); (Z.W.)
Related
- Superiority of magnetic resonance elastography and proton density fat fraction: an umbrella meta-analysis of non-invasive imaging for hepatic steatosis and fibrosis in metabolic dysfunction-associated steatotic liver disease and chronic hepatitis B.
- Natural History and Clinical Outcomes of HBeAg-Negative Chronic Hepatitis B Patients in the “Grey Zone”: A Longitudinal Cohort Study
- Course and clinical outcomes of chronic hepatitis delta: a longitudinal analysis of 565 patients from the D-SOLVE and HDV-1000 consortia
- AAV-mediated inducible expression of OSK and OSKM ameliorates acute ischemic and chronic steatotic liver disease
- Association of steatotic liver disease with long-term oncological outcomes after hepatic resection for hepatocellular carcinoma
BibTeX
@article{yang2026outcomes,
title = {{Why Outcomes Diverge in Chronic Hepatitis B with Steatotic Liver Disease: Lessons from Within-Study Contrasts}},
author = {Xiaoya Yang and Ziteng Wang and Hongshan Wei},
journal = {Medicina (Kaunas, Lithuania)},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13706878},
note = {CC BY},
}
RIS
TY - JOUR
TI - Why Outcomes Diverge in Chronic Hepatitis B with Steatotic Liver Disease: Lessons from Within-Study Contrasts
AU - Xiaoya Yang
AU - Ziteng Wang
AU - Hongshan Wei
PY - 2026
DA - 2026/10/01
JO - Medicina (Kaunas, Lithuania)
UR - https://europepmc.org/article/PMC/PMC13706878
SN - 1010-660X
SN - 1648-9144
ER -